Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
10-year high
|
Expensive Star
6906.5000
30.50
(
0.44
%)
NSE
Jul 04, 2025
15:31 PM
New 52W High today
Volume:
243.5K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
08 Aug 2020
10-year high
6906.50
0.44%
Divi's Labs (REDUCE): Q1 beat due to lumpiness retain REDUCE on full valuations
Sell:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 2850
Target
BOB Capital Markets Ltd.
Strong execution in Q1 drove a sharp 39% EBITDA beat for Divi's Labs (DIVI).
Divi's Laboratories Ltd. has gained
25.97%
in the last 3 Months
More from Divi's Laboratories Ltd.
Recommended
Five Interesting Stocks Today - July 04, 2025
The Baseline |
04 Jul 2025, 05:12PM
Market closes higher, Bajaj Finance's AUM grows 25% YoY crore in Q1FY26
Trendlyne Marketwatch |
04 Jul 2025, 04:01PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022